임상

HOME > 연구실적 > 임상 > 논문
 
작성일 : 21-06-10 10:54
논문번호 264
논문제목(영문) Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients With STEMI and Multivessel Disease Who Underwent Successful PCI Using Drug-Eluting Stents.
국내외구분 국외 SCI여부 SCI(E)
연구책임자역할 공저자
주저자명 Kim YH, Her AY
교신저자명 Kim YH
공동저자명 Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y
게제년월일 2021-01-01
ISSN 0003-3197
Impact Factor 2.255
학술지명 ANGIOLOGY
서지사항 0집 / 72권 / 1호,   페이지(50 - 61)
요약초록문
(Abstract) 입력		 To evaluate clinical implication of prediabetes, we compared a 2-year major clinical outcome including patient-oriented composite outcomes (POCOs), stent thrombosis (ST), and stroke between prediabetes and diabetes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD). A total of 4097 patients with STEMI and MVD (normoglycemia [group A: 1001], prediabetes [group B: 1518], and diabetes [group C: 1578]) who received drug-eluting stents were evaluated. Patient-oriented composite outcomes were defined as all-cause death, recurrent myocardial infarction (MI), or any repeat revascularization. The cumulative incidences of POCOs, ST, and stroke were similar between groups B and C. The cumulative incidences of all-cause death (adjusted hazard ratio [aHR]: 1.483; 95% CI: 1.027-2.143;P= .036) and all-cause death or MI (aHR: 1.429, 95% CI: 1.034-1.974;P= .031) were higher in group B than in group A. The cumulative incidences of all-cause death (aHR: 1.563; 95% CI: 1.089-2.243;P= .015), cardiac death (aHR: 1.661; 95% CI: 1.123-2.457;P= .011), and all-cause death or MI were higher in group C than in group A. In conclusion, prediabetes could potentially have a similar impact as diabetes on major clinical outcomes in patients with STEMI and MVD.
파일  C264. Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients Wit~.pdf (496.6K) DATE : 2021-06-10 10:54:38